Bharati R Dhruva
Examiner (ID: 3913)
Most Active Art Unit | 1632 |
Art Unit(s) | 1632 |
Total Applications | 2 |
Issued Applications | 1 |
Pending Applications | 1 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 4785079
[patent_doc_number] => 20080138408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-12
[patent_title] => 'Drug delivery system and method'
[patent_app_type] => utility
[patent_app_number] => 11/985263
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7881
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0138/20080138408.pdf
[firstpage_image] =>[orig_patent_app_number] => 11985263
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/985263 | Drug delivery system and method | Nov 12, 2007 | Abandoned |
Array
(
[id] => 4613171
[patent_doc_number] => 07989426
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-02
[patent_title] => 'Selective induction of apoptosis to treat ocular disease by expression of PEDF'
[patent_app_type] => utility
[patent_app_number] => 11/938562
[patent_app_country] => US
[patent_app_date] => 2007-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18407
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/989/07989426.pdf
[firstpage_image] =>[orig_patent_app_number] => 11938562
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/938562 | Selective induction of apoptosis to treat ocular disease by expression of PEDF | Nov 11, 2007 | Issued |
Array
(
[id] => 4915235
[patent_doc_number] => 20080095835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Methods for treating cancers and restenosis with P21'
[patent_app_type] => utility
[patent_app_number] => 11/981179
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5967
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0095/20080095835.pdf
[firstpage_image] =>[orig_patent_app_number] => 11981179
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/981179 | Methods for treating cancers and restenosis with P21 | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4812883
[patent_doc_number] => 20080193514
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'COMPOSTIONS AND METHODS FOR IONTOPHORESIS DELIVERY OF ACTIVE INGREDIENTS THROUGH HAIR FOLLICLES'
[patent_app_type] => utility
[patent_app_number] => 11/929451
[patent_app_country] => US
[patent_app_date] => 2007-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8295
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193514.pdf
[firstpage_image] =>[orig_patent_app_number] => 11929451
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/929451 | COMPOSTIONS AND METHODS FOR IONTOPHORESIS DELIVERY OF ACTIVE INGREDIENTS THROUGH HAIR FOLLICLES | Oct 29, 2007 | Abandoned |
Array
(
[id] => 6263199
[patent_doc_number] => 20100297214
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'PERCOLATIVE DRYING FOR THE PREPARATION OF PARTICLES'
[patent_app_type] => utility
[patent_app_number] => 12/445719
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11808
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297214.pdf
[firstpage_image] =>[orig_patent_app_number] => 12445719
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/445719 | PERCOLATIVE DRYING FOR THE PREPARATION OF PARTICLES | Oct 25, 2007 | Abandoned |
Array
(
[id] => 4676253
[patent_doc_number] => 20080213883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'SILICA NANOPARTICLES IN BASIC AMINO ACID-SILICA SOLS'
[patent_app_type] => utility
[patent_app_number] => 11/925299
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 12744
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213883.pdf
[firstpage_image] =>[orig_patent_app_number] => 11925299
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/925299 | Forming nanoparticles in basic amino acid sols | Oct 25, 2007 | Issued |
Array
(
[id] => 4892932
[patent_doc_number] => 20080102030
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-01
[patent_title] => 'PARTICLES FOR CELL TARGETING'
[patent_app_type] => utility
[patent_app_number] => 11/870077
[patent_app_country] => US
[patent_app_date] => 2007-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8604
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20080102030.pdf
[firstpage_image] =>[orig_patent_app_number] => 11870077
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/870077 | Particles for cell targeting | Oct 9, 2007 | Issued |
Array
(
[id] => 6608048
[patent_doc_number] => 20100099149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'STABILIZING COMPOSITIONS AND METHODS FOR EXTRACTION OF RIBONUCLEIC ACID'
[patent_app_type] => utility
[patent_app_number] => 12/444447
[patent_app_country] => US
[patent_app_date] => 2007-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 17489
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099149.pdf
[firstpage_image] =>[orig_patent_app_number] => 12444447
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/444447 | STABILIZING COMPOSITIONS AND METHODS FOR EXTRACTION OF RIBONUCLEIC ACID | Oct 4, 2007 | Abandoned |
Array
(
[id] => 4832950
[patent_doc_number] => 20080131497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Formulations of DNase and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 11/864127
[patent_app_country] => US
[patent_app_date] => 2007-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10215
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20080131497.pdf
[firstpage_image] =>[orig_patent_app_number] => 11864127
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/864127 | Formulations of DNase and Methods of Use Thereof | Sep 27, 2007 | Abandoned |
Array
(
[id] => 4550230
[patent_doc_number] => 07960525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-14
[patent_title] => 'Gene repair involving in vivo excision of targeting DNA'
[patent_app_type] => utility
[patent_app_number] => 11/904034
[patent_app_country] => US
[patent_app_date] => 2007-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9965
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/960/07960525.pdf
[firstpage_image] =>[orig_patent_app_number] => 11904034
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/904034 | Gene repair involving in vivo excision of targeting DNA | Sep 24, 2007 | Issued |
Array
(
[id] => 7650844
[patent_doc_number] => 20110300113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'Death Receptor CD95 Controls Neurogenesis of Adult Neural Stem Cells in Vivo and in Vitro'
[patent_app_type] => utility
[patent_app_number] => 12/442017
[patent_app_country] => US
[patent_app_date] => 2007-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12713
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0300/20110300113.pdf
[firstpage_image] =>[orig_patent_app_number] => 12442017
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/442017 | Death Receptor CD95 Controls Neurogenesis of Adult Neural Stem Cells in Vivo and in Vitro | Sep 18, 2007 | Abandoned |
Array
(
[id] => 5569828
[patent_doc_number] => 20090253206
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-08
[patent_title] => 'NUCLEAR TRANSPORT AGENT AND METHOD FOR PRODUCING SAID AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/440416
[patent_app_country] => US
[patent_app_date] => 2007-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 6992
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0253/20090253206.pdf
[firstpage_image] =>[orig_patent_app_number] => 12440416
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/440416 | NUCLEAR TRANSPORT AGENT AND METHOD FOR PRODUCING SAID AGENT | Sep 12, 2007 | Abandoned |
Array
(
[id] => 8845761
[patent_doc_number] => 08454937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-04
[patent_title] => 'Method and composition for the site-selective delivery using viruses encapsulated in microbubbles'
[patent_app_type] => utility
[patent_app_number] => 11/894821
[patent_app_country] => US
[patent_app_date] => 2007-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17124
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11894821
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/894821 | Method and composition for the site-selective delivery using viruses encapsulated in microbubbles | Aug 21, 2007 | Issued |
Array
(
[id] => 6071354
[patent_doc_number] => 20110046205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'METHOD FOR DISSOLVING CHARGED NUCLEIC ACID IN AN ORGANIC LIQUID'
[patent_app_type] => utility
[patent_app_number] => 12/377769
[patent_app_country] => US
[patent_app_date] => 2007-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4206
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 41
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046205.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377769
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377769 | METHOD FOR DISSOLVING CHARGED NUCLEIC ACID IN AN ORGANIC LIQUID | Aug 15, 2007 | Abandoned |
Array
(
[id] => 7518718
[patent_doc_number] => 07972819
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-05
[patent_title] => 'Method and apparatus for disrupting cells and amplifying nucleic acids using gold nanorods'
[patent_app_type] => utility
[patent_app_number] => 11/838550
[patent_app_country] => US
[patent_app_date] => 2007-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5827
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/972/07972819.pdf
[firstpage_image] =>[orig_patent_app_number] => 11838550
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/838550 | Method and apparatus for disrupting cells and amplifying nucleic acids using gold nanorods | Aug 13, 2007 | Issued |
61/190065 | Composition, method of preparation & application of concentrated formulations of condensed nucleic acids with a cationic lipopolymer | Aug 5, 2007 | Pending |
Array
(
[id] => 5027961
[patent_doc_number] => 20070269408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-22
[patent_title] => 'GENES OF IL-12p40 SUBUNIT MUTATED FOR IMPROVING THE ACTIVITY OF IL-12 AND USE THEREOF FOR DNA VACCINE ADJUVANT'
[patent_app_type] => utility
[patent_app_number] => 11/832993
[patent_app_country] => US
[patent_app_date] => 2007-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 15351
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20070269408.pdf
[firstpage_image] =>[orig_patent_app_number] => 11832993
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/832993 | Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant | Aug 1, 2007 | Issued |
Array
(
[id] => 5557827
[patent_doc_number] => 20090269404
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'Crosslinked Gelatin Gel, Multilayered Structure, Carrier for Bioactive Factor, Preparation for Release of Bioactive Factor, and Their Production Methods'
[patent_app_type] => utility
[patent_app_number] => 12/375920
[patent_app_country] => US
[patent_app_date] => 2007-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11255
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20090269404.pdf
[firstpage_image] =>[orig_patent_app_number] => 12375920
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/375920 | Crosslinked Gelatin Gel, Multilayered Structure, Carrier for Bioactive Factor, Preparation for Release of Bioactive Factor, and Their Production Methods | Jul 30, 2007 | Abandoned |
Array
(
[id] => 4693097
[patent_doc_number] => 20080085868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'Monoclonal Antibody 3F1H10 Neutralising VHSV (Viral Haemorrhagic Septicaemia Virus)'
[patent_app_type] => utility
[patent_app_number] => 11/829201
[patent_app_country] => US
[patent_app_date] => 2007-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4408
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0085/20080085868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11829201
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/829201 | Monoclonal Antibody 3F1H10 Neutralising VHSV (Viral Haemorrhagic Septicaemia Virus) | Jul 26, 2007 | Abandoned |
Array
(
[id] => 4909693
[patent_doc_number] => 20080020459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-24
[patent_title] => 'PROGENITOR CELL POPULATIONS, EXPANSION THEREOF, AND GROWTH OF NON-HEMATOPOIETIC CELL TYPES AND TISSUES THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 11/828575
[patent_app_country] => US
[patent_app_date] => 2007-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12459
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20080020459.pdf
[firstpage_image] =>[orig_patent_app_number] => 11828575
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/828575 | Progenitor cell populations, expansion thereof, and growth of non-hematopoietic cell types and tissues therefrom | Jul 25, 2007 | Issued |